Metabolic acidosis inhibits soft tissue calcification in uremic rats

Slides:



Advertisements
Similar presentations
M. Mizobuchi, J.L. Finch, D.R. Martin, E. Slatopolsky 
Advertisements

Volume 60, Issue 6, Pages (December 2001)
Volume 70, Issue 3, Pages (August 2006)
Sodium thiosulfate prevents vascular calcifications in uremic rats
Uremia-related vascular calcification: More than apatite deposition
The case ∣ A young woman with abdominal discomfort and a mass
Volume 69, Issue 4, Pages (February 2006)
Volume 69, Issue 8, Pages (April 2006)
Volume 67, Issue 2, Pages (February 2005)
Volume 72, Issue 1, Pages (July 2007)
Volume 85, Issue 5, Pages (May 2014)
Volume 79, Issue 10, Pages (May 2011)
Differential effects of 19-nor-1,25-(OH)2D2 and 1α-hydroxyvitamin D2 on calcium and phosphorus in normal and uremic rats  Eduardo Slatopolsky, Mario Cozzolino,
Neal X. Chen, Kalisha D. O'Neill, Danxia Duan, Sharon M. Moe 
Volume 71, Issue 3, Pages (February 2007)
Effect of acidosis on urine supersaturation and stone formation in genetic hypercalciuric stone-forming rats  David A. Bushinsky, Marc D. Grynpas, John.
Volume 60, Issue 6, Pages (December 2001)
Vascular calcification is dependent on plasma levels of pyrophosphate
Volume 64, Issue 2, Pages (August 2003)
Metformin and other antidiabetic agents in renal failure patients
Response to ‘Active renal crystal clearance in rats and humans’
A new era in phosphate binder therapy: What are the options?
Volume 81, Issue 3, Pages (February 2012)
Volume 70, Issue 11, Pages (December 2006)
Volume 54, Issue 5, Pages (November 1998)
Hyperphosphatemia of chronic kidney disease
Volume 87, Issue 2, Pages (February 2015)
Volume 71, Issue 11, Pages (June 2007)
Chemical and hormonal determinants of vascular calcification in vitro
Enlightenment on liver lanthanum exposure
Volume 80, Issue 5, Pages (September 2011)
Volume 55, Issue 2, Pages (February 1999)
Volume 69, Issue 3, Pages (February 2006)
Volume 74, Issue 10, Pages (November 2008)
Volume 70, Issue 12, Pages (December 2006)
J. Radhakrishnan, G. Markowitz, D.J. Cohen  Kidney International 
E. Neven, S. Dauwe, M.E. De Broe, P.C. D'Haese, V. Persy 
Blood pressure targets in hemodialysis patients
Effect of bolus and divided feeding on urine ions and supersaturation in genetic hypercalciuric stone-forming rats  D.A. Bushinsky, A.C. Michalenka, K.L.
Fructose intake as a risk factor for kidney stone disease
Role of vitamin D receptor activators on cardiovascular risk
Volume 75, Issue 1, Pages (January 2009)
The third World Kidney Day: Looking back and thinking forward
M. Mizobuchi, J.L. Finch, D.R. Martin, E. Slatopolsky 
Volume 72, Issue 8, Pages (October 2007)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 70, Issue 6, Pages (September 2006)
M.-J. Wu, M.-C. Wen, Y.-T. Chiu, Y.-Y. Chiou, K.-H. Shu, M.-J. Tang 
Volume 71, Issue 4, Pages (February 2007)
Volume 81, Issue 3, Pages (February 2012)
Acute phosphate nephropathy
Treatment with pyrophosphate inhibits uremic vascular calcification
Fibroblast growth factor 23: the making of a hormone
Organ transplantation goes to the movies
Volume 72, Issue 3, Pages (August 2007)
Cyril H. Barton, Zhemin Ni, Nosratola D. Vaziri  Kidney International 
Is it the low-protein diet or simply the salt restriction?
Replacing the short ammonium chloride test
Volume 70, Issue 3, Pages (August 2006)
Volume 71, Issue 9, Pages (May 2007)
Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate  S. Aime, C. Canavese, P. Stratta  Kidney International 
Volume 81, Issue 2, Pages (January 2012)
Volume 70, Issue 5, Pages (September 2006)
Volume 77, Issue 5, Pages (March 2010)
The International Pediatric Peritonitis Registry: Starting to walk
Control of uremic bone disease: Role of vitamin D analogs
Volume 61, Issue 4, Pages (April 2002)
Vascular calcification: Not so crystal clear
Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in.
Presentation transcript:

Metabolic acidosis inhibits soft tissue calcification in uremic rats F.J. Mendoza, I. Lopez, A. Montes de Oca, J. Perez, M. Rodriguez, E. Aguilera-Tejero  Kidney International  Volume 73, Issue 4, Pages 407-414 (February 2008) DOI: 10.1038/sj.ki.5002646 Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 1 Mineral content ((a) calcium, (b) phosphorus) of the aorta in sham-operated rats (Sham) and uremic rats treated with vehicle (5/6 Nx) or with calcitriol 80 ng kg−1 i.p. q.o.d. for 14 days (5/6 Nx+CTR). All groups are shown with normal pH and with acidosis, which was induced by administration of NH4Cl in drinking water at 0.75% (Sham+AC 0.75%), 0.5% (5/6 Nx+AC 0.5% and 5/6 Nx+CTR+AC 0.5%), or 0.3% (5/6 Nx+CTR+AC 0.3%). aP<0.01 vs 5/6 Nx+CTR. Kidney International 2008 73, 407-414DOI: (10.1038/sj.ki.5002646) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 2 Aortic calcification. von Kossa-stained tissue sections of the aorta in sham-operated rats (Sham, a), in uremic rats with normal pH (5/6 Nx, b) and with acidosis (5/6 Nx+AC 0.5%, c), and in uremic rats treated with calcitriol, 80 ng kg−1 i.p. q.o.d. for 14 days with normal pH (5/6 Nx+CTR, d) and with acidosis: 0.5% NH4Cl (5/6 Nx+CTR+AC 0.5%, e) and 0.3% NH4Cl (5/6 Nx+CTR+AC 0.3%, f). Kidney International 2008 73, 407-414DOI: (10.1038/sj.ki.5002646) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 3 Mineral content ((a) calcium, (b) phosphorus) of the stomach in sham-operated rats (Sham) and uremic rats treated with vehicle (5/6 Nx) or with calcitriol 80 ng kg−1 i.p. q.o.d. for 14 days (5/6 Nx+CTR). All groups are shown with normal pH and with acidosis, which was induced by administration of NH4Cl in drinking water at 0.75% (Sham+AC 0.75%), 0.5% (5/6 Nx+AC 0.5% and 5/6 Nx+CTR+AC 0.5%), or 0.3% (5/6 Nx+CTR+AC 0.3%). aP<0.01 vs 5/6 Nx+CTR, bP<0.05 vs 5/6 Nx+CTR+AC 0.3%. Kidney International 2008 73, 407-414DOI: (10.1038/sj.ki.5002646) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 4 von Kossa-stained tissue sections of the kidney and the stomach of uremic rats (5/6 Nx) treated with calcitriol, 80 ng kg−1 i.p. q.o.d. for 14 days with normal pH (5/6 Nx+CTR) and with acidosis, 0.5% NH4Cl (5/6 Nx+CTR+AC 0.5%). Kidney International 2008 73, 407-414DOI: (10.1038/sj.ki.5002646) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 5 In vitro studies of calcification using bovine VSMC incubated at normal (7.4) or low (7.2) pH with or without β-glycerophosphate (5 mM). (a) Calcium content; (b) Alizarin red stain. Kidney International 2008 73, 407-414DOI: (10.1038/sj.ki.5002646) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 6 Experimental design of the in vivo studies. Kidney International 2008 73, 407-414DOI: (10.1038/sj.ki.5002646) Copyright © 2008 International Society of Nephrology Terms and Conditions